Radical Resection
Recurrence rate: 9–18.2%
Complication rate: Up to 47%, which is high
Complete resection of the cyst wall. The reduction in recurrence rate is limited compared to the increase in complication rate.
Rathke’s cleft cyst (RCC) is a benign cystic lesion that arises when Rathke’s pouch does not completely regress during pituitary formation, and mucus accumulates in the remnant Rathke’s cleft, causing enlargement. It originates from the degenerated intermediate part (pars intermedia) between the adenohypophysis (anterior lobe) and neurohypophysis (posterior lobe).
Epidemiologically, autopsy studies report an incidence of 12–33% 1), and most are asymptomatic and discovered incidentally. Among pituitary tumors requiring surgical management, RCC accounts for only 2–9%. The peak age of onset is 30–50 years, with a female predominance (male-to-female ratio 1:1 to 1:5). Pediatric cases are rare but have been reported 5).
Both RCC and craniopharyngioma originate from the same Rathke’s cleft. The difference lies in the contents: RCC contains only fluid, whereas craniopharyngioma also contains solid components.
Both arise from the Rathke’s cleft. RCC is a benign cystic lesion containing only fluid, whereas craniopharyngioma is a neoplastic lesion with solid components and calcification. Craniopharyngioma is often more invasive and difficult to treat.
Approximately 60% of RCCs are asymptomatic. Symptomatic cases present with the following symptoms.
Because RCC is a flexible cyst, rather than directly compressing the optic chiasm, the cyst displaces the chiasm upward, and the floor of the third ventricle compresses the chiasm from above. The superonasal crossing fibers are damaged, resulting in inferiorly dominant bitemporal hemianopia.
RCC is caused by incomplete regression/closure of the Rathke’s pouch (which arises from the oral ectoderm at 3–4 weeks of gestation). Mucus accumulates and enlarges in the residual cleft, forming an RCC.
Most are located in or near the midline within the sella turcica to the suprasellar region, but rarely they may extend into the sphenoid sinus, cavernous sinus, or frontal region.
Risk factors associated with recurrence are as follows3).
Cyst size and symptom severity do not always correlate. Chronic inflammation of the cyst wall may cause symptoms independently of simple compression4).
MRI is the central imaging test for diagnosing RCC.
MRI alone may be insufficient to differentiate from cystic pituitary adenoma. The following classification methods are useful for diagnostic assistance2).
| Disease | Distinguishing Features |
|---|---|
| Cystic pituitary adenoma | Fluid-fluid level, hemorrhagic debris, septations, eccentric location |
| Craniopharyngioma | Solid component, calcification |
| Arachnoid cyst | Common in suprasellar cistern; sometimes difficult to differentiate |
| Lymphocytic hypophysitis | Pituitary gland appears as a triangle with convex superior margin |
Small asymptomatic cysts do not require surgery. Follow-up with regular imaging, endocrine tests, and visual field tests. Long-term follow-up studies of asymptomatic RCC show that most remain unchanged or shrink, with enlargement exceeding 3 mm occurring in only 5.1% of cases 5).
For symptomatic RCC, endoscopic endonasal transsphenoidal approach (EETA) is currently the standard surgical technique 1). The surgical strategy involves a combination of cyst decompression, total removal of cyst contents, partial resection of the cyst wall, and non-filling of the cyst cavity.
Radical Resection
Recurrence rate: 9–18.2%
Complication rate: Up to 47%, which is high
Complete resection of the cyst wall. The reduction in recurrence rate is limited compared to the increase in complication rate.
Partial Resection
Recurrence rate: 11–21.2%
Complication rate: Lower than radical resection
Partial resection of the cyst wall. No significant difference in recurrence rate compared to radical resection. Current standard approach.
Alcohol ablation does not reduce recurrence and increases complication risk, so it is no longer recommended 1). If visual field defects progress, prompt neurosurgical removal is necessary.
| Complication | Frequency | Course |
|---|---|---|
| Transient diabetes insipidus | 23% (14 cases) | Resolves spontaneously in about 10 days |
| Transient hypopituitarism | 11.5% (7 cases) | Improves in about 3 weeks |
| Permanent diabetes insipidus | Up to 20% | Persistent |
| Cerebrospinal fluid leak | Up to 25% | May require reoperation |
When endocrine dysfunction is predominant and visual impairment is mild, hormone replacement therapy and observation are options3)5). In inflammatory RCC, steroid therapy has been shown to potentially contribute to cyst shrinkage4), and conservative management is considered in elderly patients at high surgical risk3).
There is no significant difference in recurrence rates between radical resection and partial resection (radical resection 9–18.2%, partial resection 11–21.2%). However, radical resection has a complication rate as high as 47%, so partial resection is now the standard approach1).
Rathke’s cleft develops from the oral ectoderm at 3–4 weeks of gestation and joins with the neuroectoderm of the diencephalon to form the anterior lobe (adenohypophysis) and posterior lobe (neurohypophysis). The remnant of the intermediate part (pars intermedia) between these structures, known as Rathke’s cleft, persists, and RCCs and craniopharyngiomas arise from this site. Accumulation of mucus secreted by the epithelial cells of the cyst wall leads to cyst enlargement.
Inflammation of the cyst wall plays an important role in symptom formation. Cyst size and symptom severity do not always correlate; the inflammatory response to mucoid contents may be the main cause of headache and pituitary dysfunction4). When the cyst ruptures, xanthogranulomatous inflammation occurs2).
Because RCCs are flexible, they do not directly compress the optic chiasm. Instead, the cyst displaces structures upward, causing the floor of the third ventricle to compress the upper part of the optic chiasm, leading to damage of the superonasal nerve fibers. This results in inferior bitemporal hemianopsia.
The mechanism of spontaneous regression is not clearly understood, but hypotheses include imbalance between CSF secretion and reabsorption, cyst rupture with reabsorption of contents, and anti-inflammatory effects of steroid therapy3).
Ellens et al. (2021) reported a case of multiply recurrent RCC in which a nonabsorbable intrasellar stent using a tympanostomy tube was placed to maintain patency of the dural opening and allow continuous drainage of cyst fluid 6). No clinical or imaging recurrence was observed at 1 year postoperatively.
Conventional bioabsorbable steroid-eluting stents dissolve within 3 months, which may be insufficient to prevent late recurrence. Nonabsorbable stents may offer a long-term solution but carry risks of infection, inflammation, and migration 6).
Cuellar-Hernández et al. (2024) reported that combining the Tavakol classification with Park’s diagnostic decision tree improves preoperative differentiation between cystic pituitary adenoma and RCC 2). Radiomics and deep learning-based differentiation are also under development, but prospective studies and multicenter external validation have not yet been performed.
Hasebe et al. (2025) reported a case of RCC in a 68-year-old woman with recurrent inflammatory activity accompanied by short-term fluctuations in cyst size, in which conservative management with desmopressin alone led to resolution of headache and marked cyst shrinkage 4). Surgery is considered unlikely to improve AVP-D, and conservative management may be a valid option for inflammatory RCC.
Bano et al. (2025) reported a case of panhypopituitarism due to RCC in a 16-year-old boy managed solely with hormone replacement therapy, resulting in a 6 cm height increase and mild cyst shrinkage over 12 months 5). In a comparative analysis of 24 pediatric cases, cyst regression was observed in 35% of the conservatively managed group.
In the literature, 21 cases of spontaneous regression have been reported. In inflammatory RCC, cyst shrinkage has been achieved with conservative management (steroid therapy and hormone replacement therapy) alone 3)4). However, the course varies by individual case, so regular imaging and visual field follow-up are essential.